Products & Services


Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
News Explore

Your Oxford Nanopore guide to ASHG 2020 online

26th October 2020

ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges i...

Read more

Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants

19th October 2020

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it perfor...

Read more

Oxford Nanopore announces £84.4M in new capital

13th October 2020

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), R...

Read more

Oxford Nanopore, the Bill and Melinda Gates Foundation, Africa Centres for Disease Control and Prevention and other partners collaborate to transform disease surveillance in Africa

12th October 2020

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Afri...

Read more

LamPORE test for SARS-CoV-2 detection gains CE-IVD mark

9th October 2020

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a pa...

Read more

Interview: Improving structural variant interpretation for hereditary cancer susceptibility

5th October 2020

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed pat...

Read more

Oxford Nanopore welcomes Dr Guy Harmelin as a non-executive Director

2nd October 2020

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, ...

Read more

Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?

29th September 2020

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hea...

Read more

LamPORE evaluation study shows 99.1% sensitivity, 99.6% specificity

25th September 2020

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundati...

Read more

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

16th September 2020

New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequ...

Read more

Blog: Resolving structural variants causing antithrombin deficiency

14th September 2020

In this blog, Alba Sanchis-Juan, Javier Corral, and Belén de la Morena-Barrio describe their research into the genetic basis of thrombophilia, and how nanopore long sequencing reads were ...

Read more

Blog: Revealing the impact of structural variants on cancer susceptibility

2nd September 2020

In this blog, Katherine Dixon shares her team’s work on identifying structural variants in cancer genomes, and she explains why identifying them accurately is so important. Katherine ...

Read more

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

3rd August 2020

Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with ...

Read more

First complete assembly of human X chromosome

15th July 2020

The first telomere-to-telomere human chromosome was published in Nature this week — a landmark achievement for genomics researchers. Lead author Karen Miga, from the UC Santa Cruz Genomi...

Read more

Interview: Identification of structural variation in chimpanzees using optical mapping and nanopore sequencing

10th July 2020

Daniela Soto is a Ph.D. candidate in the Integrative Genetics and Genomics program at UC Davis, working in the Dennis Lab where she is using long-read sequencing technologies to unveil ...

Read more

LamPORE for SARS-CoV-2 detection: the science behind the new assay

20th June 2020

LamPORE is a new assay, in advanced development at Oxford Nanopore. It is designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in a saliva, swab or environmenta...

Read more

Oxford Nanopore announces pathway to diagnostics and other regulated markets

19th June 2020

Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulat...

Read more

London Calling 2020

18th June 2020

London Calling this year took a very different format, going online for the first time ever. With over 5,500 people tuning in to see the action, either live or on-demand, it was a fantast...

Read more

G42 and ONT Co-Develop Ultra-Scalable Solution for COVID-19 Detection (UAE)

9th June 2020

End-to-end solution will enable mass/on-demand screening to support the re-opening of global economies. Abu Dhabi; June 09, 2020: Group 42 (G42), a leading AI and Cloud Computing compan...

Read more

Blog: Ruminating on the rumen microbiome

9th June 2020

In this blog, Beatriz Delgado Corrales, Óscar González Recio, and Mónica Gutiérrez Rivas describe their work on classifying rumen microbiomes, comparing long-read and short-read sequencin...

Read more

Oxford Nanopore announces £48.4M ($59.2M) in new capital to support ongoing innovation and the rapid worldwide growth of nanopore sequencing

26th May 2020

26th May 2020, Oxford, UK: Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, a...

Read more

Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection

22nd May 2020

LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay...

Read more

96 barcodes: Expanded PCR-free multiplexing capacity for lower cost per sample – now available in store

21st May 2020

Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell - including for SARS-CoV-2 whole genome sequenci...

Read more

Oxford Nanopore supports COVID-19 pandemic: epidemiology and research

21st May 2020

Please visit our updated COVID mini-site Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pa...

Read more

MinION Mk1C now in-field, for COVID-19 and beyond

19th May 2020

From COVID-19 research and epidemiology to plant genomics, analysis of eDNA to whole genome sequencing, the applications of MinION Mk1C are now being thoroughly explored by the Nanopore C...

Read more
Open a chat to talk to our sales team